This resolution expresses the House of Representatives' support for the United States ratifying the Rome Statute to become a full member of the International Criminal Court. The bill calls for lifting current sanctions and visa restrictions on ICC personnel and encourages the U.S. to persuade other nations to join the court. It frames joining the court as a way to uphold American values of justice and accountability while allowing the U.S. to influence the court's priorities.
This resolution asks the President and the Secretary of Health and Human Services to provide the House of Representatives with specific documents regarding a freeze on federal payments to five states. The requested materials include communications about how the payment freeze was decided, records of the tweet that announced it, and details on funding drawdowns, disciplinary actions, and data sharing plans related to those states. The bill specifically targets documents concerning Temporary Assistance for Needy Families, Child Care, and Social Services Block Grant programs in California, Colorado, Illinois, Minnesota, and New York. If the agencies possess the records, they must submit them to Congress within 14 days of the resolution's adoption.
The Work Without Worry Act of 2026 changes how the Social Security Administration evaluates disability for children who receive benefits based on a parent's work record. It allows these children to be considered disabled even if their condition started before age 22 but continued after that age, removing the requirement that they remain disabled continuously until they apply for benefits. Additionally, the bill treats a child's application for benefits as a simultaneous request for their own disability or retirement benefits if they meet specific age and insurance criteria, though they will only receive the higher payment amount. These changes apply to applications filed at least two years after the law is enacted.
The Pharmaceutical Investment Oversight and Accountability Act requires the Federal Trade Commission to produce an annual report on foreign investment within the U.S. pharmaceutical industry. This report must assess how foreign ownership affects domestic drug manufacturing, supply chains, and the capacity to sequence or store DNA. The FTC will also review past investigations into these foreign transactions to determine how many were approved or blocked. Finally, the agency must publish a public summary of its findings on its website and share the full report with specific congressional committees.
The Language Access for All Act of 2026 requires all federal agencies to ensure individuals with limited English proficiency can meaningfully access government programs and services. To achieve this, agencies must translate vital documents into frequently encountered languages, add multilingual features to digital systems, and provide oral interpretation services, while also establishing a dedicated Language Access Coordinator in each agency. The bill mandates the creation of detailed language access plans and technical standards that cover both traditional communication methods and artificial intelligence tools, ensuring that AI is used only to assist rather than replace human interpreters. A new public complaint system will be established to track barriers to access, and agencies will be required to submit their plans and annual compliance reports to the Attorney General and Congress. Noncompliance with these requirements will be treated as discrimination under Title VI of the Civil Rights Act, allowing the Department of Justice to investigate and enforce the law.
This bill requires wagering and prediction market platforms to use facial recognition technology to verify that all users are over 18 years old before allowing them to place bets or orders. To protect user privacy, the law mandates that these platforms collect only the data strictly necessary for age verification and must delete any such data once it is no longer needed. The Federal Trade Commission is given the authority to enforce these age verification rules and can issue penalties for violations. Additionally, the legislation establishes a new Office of the Retail Advocate and an Advisory Council within the Commodity Futures Trading Commission to better protect individual investors and oversee the regulation of event contracts.
The Drug Deal Disclosure Act requires the Department of Health and Human Services to publicly release records of specific agreements between the federal government and major drug manufacturers starting in 2025. These agreements must include provisions such as offering lower drug prices based on international rates, providing discounts through government platforms like TrumpRx, or receiving special exemptions from import duties and regulatory reviews. While the bill mandates that most documents be made available in a searchable format, it allows the government to withhold only specific confidential pricing details if legally required by foreign laws or court orders, provided a justification is published. Additionally, the law directs the Congressional Budget Office and the Government Accountability Office to analyze the economic and budgetary impacts of these deals, including effects on Medicare, Medicaid, and drug competition.
The Patients First Act of 2026 modifies how Medicare reimburses physicians and primary care providers to improve access and stabilize payments. It establishes a new hybrid payment model for primary care services from 2027 to 2031, which pays a monthly fee per patient to eligible independent practices while covering specific services like care management and telehealth without cost-sharing for patients. The bill also updates the formula for calculating reimbursement rates to account for high inflation years and requires more frequent updates to the costs used in calculating payments. Additionally, the legislation reforms the performance-based payment system by adding care efficiency measures, creating a task force to recommend new quality metrics, and adjusting penalties for providers who fail to report on certain data.
The Medicare Access to Rural Anesthesiology Act changes how Medicare pays for anesthesia services at specific small rural hospitals and critical access hospitals. To qualify for these changes, a hospital must be located in a rural area, have fewer than 800 surgeries requiring anesthesia, and employ or contract with no more than one full-time anesthesiologist who agrees not to bill Medicare separately for those services. Once a hospital meets these criteria, anesthesia care provided by an anesthesiologist there will be paid based on the hospital's actual costs rather than a fixed fee, and it will be classified as part of the hospital's inpatient services instead of a separate billable service. The law also requires the Department of Health and Human Services to update its regulations to reflect these new payment rules.
The Essential Caregivers Act of 2026 requires nursing homes, long-term care hospitals, rehabilitation facilities, and intermediate care facilities to allow two chosen family members or friends to visit residents during times when regular visitation is suspended. These essential caregivers must agree to follow the facility's existing safety and infection control rules, which are no more restrictive than those applied to staff. While facilities can limit access for the first seven days of a suspension or deny entry if a caregiver shows symptoms of a serious infectious disease, they cannot block visits for end-of-life care. Additionally, the bill mandates that complaints about denied access to essential caregivers be investigated and resolved within three days.
This resolution expresses strong disapproval of local prosecution policies that allegedly offer special leniency to foreign nationals compared to U.S. citizens. It argues that such practices endanger public safety and violate federal civil rights laws by failing to treat all individuals equally under the law. The text calls on state and local prosecutors to ignore immigration status when deciding how to handle criminal cases and urges the Department of Justice to investigate these alleged preferential treatments. Ultimately, the measure aims to ensure that every crime is prosecuted to the fullest extent of the law regardless of the suspect's background.
HR 7184, the PRESS Act, targets equipment used to manufacture illegal drugs by making it unlawful to sell specific items like tableting machines, gelatin capsules, or related chemicals when the seller knows the equipment will be used to produce controlled substances for unlawful U.S. importation. It directly affects manufacturers and distributors of these drug-making tools who have knowledge or reasonable cause to believe their products will facilitate illegal drug trafficking. The bill adds new prohibitions to the Controlled Substances Act and increases potential prison sentences for violations, with penalties reaching up to 20 years for major offenses involving large quantities of equipment or chemicals. These changes aim to disrupt the supply chain for illicit synthetic drugs by holding equipment sellers accountable for their intended use.
